GREAT POINT PARTNERS LLC 4

Accession 0000930413-11-000885

CIK 0001337013other

View on SEC.gov Company Profile

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 5:19 PM ET

Size

26.4 KB

Accession

0000930413-11-000885

Insider Transaction Report

Form 4

Period: 2011-02-08

InfuSystem Holdings, IncINFU

JAY JEFFREY R

10% Owner

Transactions

Sale
Common Stock
2011-02-10$2.23/sh−1,874,290$4,173,856→ 0 total(indirect: By Biomedical Value Fund, L.P.)
Sale
Common Stock
2011-02-08$2.75/sh−110,252$303,193→ 1,874,290 total(indirect: By Biomedical Value Fund, L.P.)
Sale
Common Stock
2011-02-08$2.75/sh−115,000$316,250→ 1,955,000 total(indirect: By Biomedical Offshore Value Fund, Ltd.)
Sale
Common Stock
2011-02-08$2.75/sh−24,748$68,057→ 420,710 total(indirect: By Biomedical Institutional Value Fund, L.P.)
Sale
Common Stock
2011-02-10$2.23/sh−1,955,000$4,353,590→ 0 total(indirect: By Biomedical Offshore Value Fund, Ltd.)
Sale
Common Stock
2011-02-10$2.23/sh−420,710$936,879→ 0 total(indirect: By Biomedical Institutional Value Fund, L.P.)

Holdings

Option (right to buy)
(indirect: By Biomedical Offshore Value Fund, Ltd.)
→ Warrant (766,666.36 underlying)
766,666.36
Option (right to buy)
(indirect: By Biomedical Value Fund, L.P.)
Exercise: $6.25Exp: 2011-04-11→ Common Stock (899,999.64 underlying)
899,999.64
Option (right to buy)
(indirect: By Biomedical Offshore Value Fund, L.P.)
Exercise: $6.25Exp: 2011-04-11→ Common Stock (766,666.36 underlying)
766,666.36
Option (right to buy)
(indirect: By Biomedical Value Fund, L.P.)
→ Warrant (899,999.64 underlying)
899,999.64

KROIN DAVID

10% Owner

Transactions

Sale
Common Stock
2011-02-08$2.75/sh−110,252$303,193→ 1,874,290 total(indirect: By Biomedical Value Fund, L.P.)
Sale
Common Stock
2011-02-08$2.75/sh−24,748$68,057→ 420,710 total(indirect: By Biomedical Institutional Value Fund, L.P.)
Sale
Common Stock
2011-02-10$2.23/sh−1,874,290$4,173,856→ 0 total(indirect: By Biomedical Value Fund, L.P.)
Sale
Common Stock
2011-02-10$2.23/sh−1,955,000$4,353,590→ 0 total(indirect: By Biomedical Offshore Value Fund, Ltd.)
Sale
Common Stock
2011-02-08$2.75/sh−115,000$316,250→ 1,955,000 total(indirect: By Biomedical Offshore Value Fund, Ltd.)
Sale
Common Stock
2011-02-10$2.23/sh−420,710$936,879→ 0 total(indirect: By Biomedical Institutional Value Fund, L.P.)

Holdings

Option (right to buy)
(indirect: By Biomedical Value Fund, L.P.)
→ Warrant (899,999.64 underlying)
899,999.64
Option (right to buy)
(indirect: By Biomedical Value Fund, L.P.)
Exercise: $6.25Exp: 2011-04-11→ Common Stock (899,999.64 underlying)
899,999.64
Option (right to buy)
(indirect: By Biomedical Offshore Value Fund, Ltd.)
→ Warrant (766,666.36 underlying)
766,666.36
Option (right to buy)
(indirect: By Biomedical Offshore Value Fund, L.P.)
Exercise: $6.25Exp: 2011-04-11→ Common Stock (766,666.36 underlying)
766,666.36

GREAT POINT PARTNERS LLC

10% Owner

Transactions

Sale
Common Stock
2011-02-08$2.75/sh−115,000$316,250→ 1,955,000 total(indirect: By Biomedical Offshore Value Fund, Ltd.)
Sale
Common Stock
2011-02-10$2.23/sh−1,874,290$4,173,856→ 0 total(indirect: By Biomedical Value Fund, L.P.)
Sale
Common Stock
2011-02-10$2.23/sh−420,710$936,879→ 0 total(indirect: By Biomedical Institutional Value Fund, L.P.)
Sale
Common Stock
2011-02-08$2.75/sh−110,252$303,193→ 1,874,290 total(indirect: By Biomedical Value Fund, L.P.)
Sale
Common Stock
2011-02-08$2.75/sh−24,748$68,057→ 420,710 total(indirect: By Biomedical Institutional Value Fund, L.P.)
Sale
Common Stock
2011-02-10$2.23/sh−1,955,000$4,353,590→ 0 total(indirect: By Biomedical Offshore Value Fund, Ltd.)

Holdings

Option (right to buy)
(indirect: By Biomedical Offshore Value Fund, Ltd.)
→ Warrant (766,666.36 underlying)
766,666.36
Option (right to buy)
(indirect: By Biomedical Offshore Value Fund, L.P.)
Exercise: $6.25Exp: 2011-04-11→ Common Stock (766,666.36 underlying)
766,666.36
Option (right to buy)
(indirect: By Biomedical Value Fund, L.P.)
→ Warrant (899,999.64 underlying)
899,999.64
Option (right to buy)
(indirect: By Biomedical Value Fund, L.P.)
Exercise: $6.25Exp: 2011-04-11→ Common Stock (899,999.64 underlying)
899,999.64

Footnotes (9)

[F1]Great Point Partners, LLC ("Great Point") is the investment manager of Biomedical Value Fund, L.P. ("BMVF") and by virtue of such status may be deemed to be the beneficial owner of the shares and options held by BMVF. Each of Dr. Jeffrey R. Jay, M.D. (Dr. "Jay"), as senior managing member of Great Point, and Mr. David Kroin ("Mr. Kroin"), as special managing member of Great Point, has voting and investment power with respect to the shares held by BMVF and may be deemed to be the beneficial owner of the shares and options held by BMVF. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the shares and options held by BMVF, except to the extent of any pecuniary interest, and this report shall not be deemed to be an admission that they are the beneficial owners of such securities.
[F2]Great Point is the investment manager of Biomedical Offshore Value Fund, Ltd. ("BOVF") and by virtue of such status may be deemed to be the beneficial owner of the shares and options held by BOVF. Each of Dr. Jay, as senior managing member of Great Point, and Mr. Kroin, as special managing member of Great Point, has voting and investment power with respect to the shares held by BOVF and may be deemed to be the beneficial owner of the shares and options held by BOVF. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the shares and options held by BOVF, except to the extent of any pecuniary interest, and this report shall not be deemed to be an admission that they are the beneficial owners of such securities.
[F3]Great Point is the investment manager of Biomedical Institutional Value Fund, L.P. ("BIVF") and by virtue of such status may be deemed to be the beneficial owner of the shares and options held by BIVF. Each of Dr. Jay, as senior managing member of Great Point, and Mr. Kroin, as special managing member of Great Point, has voting and investment power with respect to the shares held by BIVF and may be deemed to be the beneficial owner of the shares [and options] held by BIVF. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the shares and options held by BIVF, except to the extent of any pecuniary interest, and this report shall not be deemed to be an admission that they are the beneficial owners of such securities.
[F4]$.0000006.
[F5]On October 15, 2007, BMVF was assigned options to acquire warrants to purchase 899,999.64 shares of Common Stock of the Issuer by Great Point. Great Point acquired such options to acquire such warrants pursuant to an Option Agreement, dated as of October 12, 2007 (the "FTN Option Agreement"), by and between Great Point and FTN Midwest Securities Corp. Pursuant to the FTN Option Agreement, such options to acquire such warrants are exercisable upon the satisfaction of certain conditions, including the trading price for per of Common Stock of the Issuer equaling or exceeding $8.00 for any 20 out of 30 consecutive trading days.
[F6]Not applicable.
[F7]On October 15, 2007, BOVF was assigned options to acquire warrants to purchase 766,666.36 shares of Common Stock of the Issuer by Great Point. Great Point acquired such options to acquire warrants pursuant to the FTN Option Agreement. Pursuant to the FTN Option Agreement, such options to acquire such warrants are exercisable upon the satisfaction of certain conditions, including the trading price for per of Common Stock of the Issuer equaling or exceeding $8.00 for any 20 out of 30 consecutive trading days.
[F8]The exercise price of the warrants is subject to adjustment for dividends with respect to, or subdivisions, combinations, reclassifications of, the Issuer's common stock.
[F9]Exercisable immediately.

Documents

1 file

4
c64329_form4.xmlPrimary

Issuer

InfuSystem Holdings, Inc

CIK 0001337013

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001281446

Filing Metadata

Form type: 4
Filed: Feb 9, 7:00 PM ET
Accepted: Feb 10, 5:19 PM ET
Size: 26.4 KB

View on SEC.gov